EPIDERMOLYSIS BULLOSA ACQUISITA

Clinical trials for EPIDERMOLYSIS BULLOSA ACQUISITA explained in plain language.

Never miss a new study

Get alerted when new EPIDERMOLYSIS BULLOSA ACQUISITA trials appear

Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA ACQUISITA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to heal fragile skin

Disease control Recruiting now

This study is testing if adding an IV immunoglobulin (IV IgG) treatment to an existing gene therapy (VYJUVEK) helps wounds heal better in people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a severe genetic skin condition. The main goal is to see if this combination re…

Matched conditions: EPIDERMOLYSIS BULLOSA ACQUISITA

Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

EPIDERMOLYSIS BULLOSA ACQUISITA

Get alerted when new EPIDERMOLYSIS BULLOSA ACQUISITA trials appear

New combo therapy aims to heal fragile skin